• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Medicare Expands Coverage of Molecular Cancer Screening Tests

Medicare Expands Coverage of Molecular Cancer Screening Tests

by Glenn S. Demby | May 4, 2023 | Essential, Laboratory Industry Report, Reimbursement-lir

In terms of Medicare coverage, 2023 is shaping up to be a fruitful year—here are five of the most significant approvals so far.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
AACC Offers New Guidance for HPV and Cervical Cancer Screening

AACC Offers New Guidance for HPV and Cervical Cancer Screening

by Glenn S. Demby | Apr 24, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

New document aims to help clinicians navigate screening guidelines, choose testing strategies, and analyze test results.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests

New Tech Could Improve Diagnostic Accuracy of Prostate Cancer Tests

by Ali Tinazli, PhD, Chief Executive Officer, Lifespin | Mar 23, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

New technologies show potential for far greater accuracy and the ability to customize treatment options to improve outcomes.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A New ctDNA Test for MRD Surveillance in Colorectal Cancer Patients

A New ctDNA Test for MRD Surveillance in Colorectal Cancer Patients

by Damon Anderson, PhD | Mar 22, 2023 | Clinical Diagnostics Insider, Diagnostic Testing and Emerging Technologies, Special Focus-dtet

The personalized test is designed to help inform post-surgery adjuvant therapies in CRC patients.

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
New Guidance Released for Cervical Cancer Detection

New Guidance Released for Cervical Cancer Detection

by Rachel Muenz | Mar 21, 2023 | News, Open Content

Recently released AACC document covers newly updated screening guidelines as well as information on surveillance and diagnosis.

« Older Entries
Next Entries »

Sign up for our free weekly Lab & Pathology Insider email newsletter

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com